Thermophilic dna polymerase mutants
Abstract
This disclosure relates to thermophilic family B DNA polymerases comprising a neutral amino acid residue at a certain position near the C-terminus of the catalytic domain, which corresponds to a position occupied by a basic amino acid residue in wild-type Pfu polymerase. The thermophilic family B DNA polymerases provided herein also comprise an N-terminal domain comprising a uracil-binding pocket that has been modified to reduce template uracil binding. Related uses, methods, and compositions are also provided. In some embodiments, the polymerases comprise a 3′-5′ exonuclease domain and/or a sequence nonspecific dsDNA binding domain.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 - 55 . (canceled)
56 . A nucleic acid comprising a sequence encoding a thermophilic DNA polymerase comprising a family B polymerase N-terminal domain comprising a uracil-binding pocket and a family B polymerase catalytic domain, the family B polymerase N-terminal domain comprising a uracil-binding pocket having an amino acid sequence in which the position corresponding to position 36 of SEQ ID NO: 1 is any amino acid other than P, and the family B polymerase catalytic domain having an amino acid sequence in which the position corresponding to position 762 of SEQ ID NO: 1 is a neutral amino acid residue,
wherein the thermophilic DNA polymerase comprises an amino acid sequence having at least 90%, 95%, 98%, 99%, or 100% identity to a sequence selected from SEQ ID NOs: 80 to 113 and 127 to 160, wherein X 1 is any amino acid other than P and X 2 is the neutral amino acid residue.
57 . An expression vector comprising the nucleic acid of claim 56 .
58 . An isolated host cell comprising the expression vector of claim 57 .
59 . A method of producing a thermophilic DNA polymerase, comprising culturing at least one host cell comprising a the nucleic acid of claim 56 , wherein the at least one host cell expresses the thermophilic DNA polymerase.
60 . The method of claim 59 , further comprising isolating the thermophilic DNA polymerase.
61 . A composition comprising the nucleic acid of claim 56 .
62 . The composition of claim 61 , comprising at least one hot start inhibitor.
63 . The composition of claim 61 , comprising at least two hot start inhibitors.
64 . The composition of claim 62 , wherein each hot start inhibitor is independently selected from an antibody, an Affibody®, a chemical modification, and an oligonucleotide.
65 . The composition of claim 63 , wherein the composition comprises at least two antibodies.
66 . The composition of claim 63 , wherein the composition comprises an antibody and an oligonucleotide.
67 - 104 . (canceled)
105 . An isolated host cell comprising the nucleic acid of claim 56 .
106 . The composition of claim 63 , wherein each hot start inhibitor is independently selected from an antibody, an Affibody®, a chemical modification, and an oligonucleotide.
107 . The composition of claim 64 , wherein the composition comprises at least two antibodies.
108 . The composition of claim 64 , wherein the composition comprises an antibody and an oligonucleotide.Join the waitlist — get patent alerts
Track US2023357732A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.